Shari Messinger

Medicine & Life Sciences

1. Islets of Langerhans Transplantation 100%
2. Type 1 Diabetes Mellitus 66%
3. Transplants 59%
4. Exenatide 43%
5. Allografts 41%
6. C-Peptide 32%
7. Transplant Recipients 32%
8. Glucose 30%
9. Insulin 30%
10. Islets of Langerhans 24%
11. Immunosuppression 20%
12. fibroblast growth factor 23 16%
13. HIV 16%
14. Pancreas 16%
15. Tissue Donors 15%
16. Quality of Life 15%
17. Kidney 14%
18. Dental Care 14%
19. Kidney Transplantation 12%
20. Oral Health 12%
21. Autoimmunity 12%
22. Cell Survival 12%
23. Mesenchymal Stem Cells 10%
24. Type 2 Diabetes Mellitus 9%
25. Diabetic Retinopathy 9%
26. 1,5-anhydroglucitol 9%
27. Homologous Transplantation 9%
28. iodixanol 9%
29. Minerals 9%
30. Dentists 9%
31. Cell Transplantation 8%
32. Sirolimus 8%
33. Autoantibodies 8%
34. Calcineurin Inhibitors 8%
35. Pancreas Transplantation 8%
36. Therapeutics 7%
37. Delivery of Health Care 7%
38. Niacinamide 7%
39. Disease Progression 7%
40. Immunoglobulin gamma-Chains 7%
41. Female Genitalia 7%
42. Hypoglycemia 7%
43. Meals 6%
44. Recurrence 6%
45. Umbilical Cord 6%
46. Liberase 6%
47. Randomized Controlled Trials 6%